Aspirin
- Product NDC
- 11534-155
- 11-digit product format
- 115340155
- Labeler code
- 11534
- Product ID
- 11534-155_5fdaba26-4c64-4896-a89a-69fefec6e563
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Sunrise Pharmaceutical Inc
- Application
- part343
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2010-01-03
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN
- Active strength
- 81 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11534-155-11 | Aspirin | 120 in 1 BOTTLE | TABLET, DELAYED RELEASE | 120 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11534-155 | ASPIRIN TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | Legacy NDC, 1 package rows | 20110107_eae5797a-0f4d-4b80-bd48-2445c2b74b25.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 11534-155-11 | 11534015511 | 120 in 1 BOTTLE | Historical |